NCT01429818

Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients

Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients. Positron Emission Tomography Assessment(PET)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Laboratorios Silanes S.A. de C.V. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The Purpose of this study was to evaluate the effect of the combination glimepiride/metformin over endothelial dysfunction (ED) in asymptomatic patients with type 2 diabetes mellitus (DM) using 13N-ammonia-positron emission tomography (PET).

Conditions

• Endothelial Dysfunction
• Diabetes Mellitus

Interventions

Type	Name	Description
DRUG	Glimepiride/metformin	4/1000 mg tablets once a day foe eight weeks
DRUG	Metformin	1000 mg tablets once daily for eight weeks

Timeline

• Start date: 2007-07-01
• Primary completion: 2008-01-01
• Completion: 2008-01-01
• First posted: 2011-09-07
• Last updated: 2011-09-07

Locations

1 site across 1 country: Mexico